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Cancer is a leading cause of death worldwide, and most drugs currently available for the 
treatment of cancer have limited potential. Natural products or their structural relatives have been 
the mainstay of cancer chemotherapy for the past few decades and still comprise about 50% of 
the drugs that are used for cancer chemotherapy. Curcumin is one of the natural drugs that 
recently attracted close attention due to its putative cancer-preventing and even anticancer 
properties on its own. In addition, since its discovery as a crucial signaling molecule, great hopes 
are emerging for new Nitric Oxide-based treatments of a wide variety of diseases. Here, we 
tested the anti-cancer effects of Nitro-Curcumin. We hypothesized that by joining the effects of 
curcumin and NO in one compound, the treatment and prevention of cancer will be more potent 
than curcumin alone since this compound retains the pharmacological activity of the parent 
compound curcumin and also has the biological actions of NO, a strategy that has not been 
implemented before in cancer treatment and prevention. To compare the anti-cancer effects of 
curcumin and NO-curcumin, we treated different cancer cell lines using both compounds and 
tested their effects on different cancer cell lines’ proliferation and death. Because colitis is a 
colon cancer predisposing factor, we evaluated the anti-inflammatory effect of NO-curcumin in 
mice in vivo using dextran sulfate-induced colitis model. Our results showed that NO-curcumin 
is more effective in reducing cell proliferation and increasing cell death when compared to 
curcumin alone. In addition NO-curcumin has a lower half maximal inhibitory concentration 
(IC50) compared to curcumin. Altogether, our results demonstrate, for the first time, that NO-
curcumin has more potent anti-cancer and anti-inflammatory effects, which makes it a potential 
future treatment for cancer and inflammation. 
